Drug Target Review2026-01-19T10:00:00
Complex diseases rarely have single targets. By focusing on transcription factor activity and disease signatures, Scripta Therapeutics is taking a different approach to identifying the drivers of pathology.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-11-17T09:31:00Z
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2026-10-21T14:02:00
Contributor Jim Corbett, Drug Target Review
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, Drug Target Review
Site powered by Webvision Cloud